Why Routine Smallpox Vaccination Stopped: Eradication, Risks, and Preparedness
Routine smallpox vaccination ceased globally in the 1970s–80s after WHO certified eradication (1980). Six reasons:
- Eradication achieved: No natural transmission since 1977; variola virus exists only in two high-containment labs (CDC, VECTOR).
- Near-zero re-emergence risk: No animal reservoir; environmental persistence negligible.
- Vaccine adverse events: Live vaccinia virus caused eczema vaccinatum, progressive vaccinia, postvaccinal encephalitis, myocarditis—~1–2 deaths/million doses.
- Resource reallocation: Funds/logistics redirected to ongoing threats (polio, measles, HIV, TB).
- International cooperation model: Demonstrated global solidarity; framework for future eradication campaigns.
- Ongoing preparedness: Strategic stockpiles (300M+ doses), rapid-response plans, lab surveillance maintained.
Vaccination continues only for lab workers handling orthopoxviruses and select military personnel.
Viral Infections - Related Articles
- Smallpox: Symptoms, History, and Current Status
- Viral Envelope: Structure, Composition & Function
- History of Smallpox: Earliest Evidence from Ancient Egypt
- Understanding AIDS in Colombia: Impact of Conflict & Poverty
- Rabies & Hydrophobia: Neurobiology of the "Fear of Water"
- John Snow's Cholera Investigation: The Birth of Modern Epidemiology
- Flu Vaccine for Toddlers: Risks, Benefits & What to Expect
